COVID-19 and Type 1 Diabetes: Concerns and Challenges.
Journal
Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064
Informations de publication
Date de publication:
07 09 2020
07 09 2020
Historique:
received:
30
07
2020
accepted:
30
07
2020
entrez:
14
9
2020
pubmed:
15
9
2020
medline:
23
9
2020
Statut:
epublish
Résumé
Due to the current COVID-19 pandemic, worldwide population's lifestyle has changed dramatically, causing psychosocial consequences. Patients presenting a preexisting chronic condition, as Type 1 Diabetes (T1D), are the ones suffering the most from this situation. Moreover, people affected by diabetes are the ones with the worst prognosis, if infected by SARS-CoV-2. We analyzed why patients with T1D were poorly represented between the subjects hospitalized for COVID-19 and why the cases of diabetic ketoacidosis (DKA) were fewer and more severe compared with the past years. Furthermore, literature has showed how patients of all ages with T1D did not experience a deterioration in their glucose control throughout the lockdown. Among other causes, this is also due to the surging use of telemedicine. Finally, we tried to understand how the coronavirus tropism for endocrine tissues could influence the future epidemiology of T1D, focusing on the effects they have on pancreatic β-cells.
Identifiants
pubmed: 32921727
doi: 10.23750/abm.v91i3.10366
pmc: PMC7716973
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2020033Références
Acta Diabetol. 2010 Sep;47(3):193-9
pubmed: 19333547
Diabetes Res Clin Pract. 2020 Jun 12;:108270
pubmed: 32540326
Clinics (Sao Paulo). 2005 Feb;60(1):61-70
pubmed: 15838583
Diabetes Technol Ther. 2020 Jun;22(6):462-467
pubmed: 32421355
Diabetes Res Clin Pract. 2020 Jun;164:108219
pubmed: 32442555
Diabetes Care. 2020 Aug;43(8):1690-1694
pubmed: 32540920
Diabetes Metab. 2020 May 21;:
pubmed: 32447100
Diabetes Care. 2020 Nov;43(11):2870-2872
pubmed: 32778554
Diabetes Res Clin Pract. 2020 Aug;166:108302
pubmed: 32623034
Curr Diab Rep. 2018 May 24;18(7):42
pubmed: 29797292
Cell Stem Cell. 2020 Jul 2;27(1):125-136.e7
pubmed: 32579880
Diabetes Care. 2020 Aug;43(8):e83-e85
pubmed: 32503837
Diabetes Technol Ther. 2020 May 12;:
pubmed: 32396400
Acta Diabetol. 2020 Oct;57(10):1265-1266
pubmed: 32653960
Diabetologia. 2017 Oct;60(10):1931-1940
pubmed: 28770319
Mol Cell Endocrinol. 2009 Apr 29;302(2):193-202
pubmed: 18948167
J Clin Endocrinol Metab. 2020 Apr 1;105(4):
pubmed: 31863667
Diabetes Res Clin Pract. 2020 Sep;167:108306
pubmed: 32623033
Nat Rev Endocrinol. 2016 May;12(5):263-273
pubmed: 27020257
Diabetes Ther. 2020 May 11;:1-11
pubmed: 32395187
J Diabetes Sci Technol. 2017 May;11(3):468-475
pubmed: 28745094
J Diabetes Sci Technol. 2020 Jul;14(4):811-812
pubmed: 32468840
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):395-403
pubmed: 32334395
Med Hypotheses. 2020 Sep;142:109795
pubmed: 32416410
Front Pediatr. 2020 Jul 31;8:491
pubmed: 32850562
Lancet Diabetes Endocrinol. 2020 Sep;8(9):782-792
pubmed: 32687793
Diabetes Res Clin Pract. 2020 Jun;164:108220
pubmed: 32442557
Pediatr Infect Dis J. 2020 Jul;39(7):e137-e140
pubmed: 32404790
Lancet Diabetes Endocrinol. 2020 Oct;8(10):813-822
pubmed: 32798472
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789